BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35936962)

  • 1. Usefulness of ultrasound fusion technology for hepatocellular carcinoma localisation, pre- and post-thermal ablation.
    Afif AM; Laroco OD; Lau S; Teo SM; Rahman AA; Too CW; Venkatanarasimha N; Gogna A
    Ultrasound; 2022 Aug; 30(3):194-200. PubMed ID: 35936962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound.
    Ju JX; Zeng QJ; Xu EJ; He XQ; Tan L; Huang QN; Li K; Zheng RQ
    Int J Hyperthermia; 2019; 36(1):785-793. PubMed ID: 31431086
    [No Abstract]   [Full Text] [Related]  

  • 3. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
    Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image Guidance in Ablation for Hepatocellular Carcinoma: Contrast-Enhanced Ultrasound and Fusion Imaging.
    Minami Y; Kudo M
    Front Oncol; 2021; 11():593636. PubMed ID: 33747913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma - A prospective randomized controlled trial.
    Huang Q; Zeng Q; Long Y; Tan L; Zheng R; Xu E; Li K
    Int J Hyperthermia; 2019; 36(1):1207-1215. PubMed ID: 31813295
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors.
    Xu E; Long Y; Li K; Zeng Q; Tan L; Luo L; Huang Q; Zheng R
    Int J Hyperthermia; 2019 Jan; 35(1):159-167. PubMed ID: 30300032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
    Lee MW; Lim HK; Rhim H; Cha DI; Kang TW; Song KD; Min JH; Gwak GY; Kim S; Lu DSK
    Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter.
    Calandri M; Ruggeri V; Carucci P; Mirabella S; Veltri A; Fonio P; Gazzera C
    Radiol Med; 2019 Oct; 124(10):1043-1048. PubMed ID: 31270723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image fusion in the management of thermal tumor ablation of the liver.
    Clevert DA; Paprottka PM; Helck A; Reiser M; Trumm CG
    Clin Hemorheol Microcirc; 2012; 52(2-4):205-16. PubMed ID: 22960300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound fusion imaging technologies for guidance in ablation therapy for liver cancer.
    Minami Y; Kudo M
    J Med Ultrason (2001); 2020 Apr; 47(2):257-263. PubMed ID: 32125577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization.
    Gu JH; Zhao QY; He C; Ye ZD; Xu M; Jiang TA
    Int J Hyperthermia; 2021; 38(1):1092-1098. PubMed ID: 34296656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
    Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
    Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
    Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
    Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
    Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
    Wang Y; Jing X; Ding J
    Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast ultrasound in hepatocellular carcinoma at a tertiary liver center: First Indian experience.
    Laroia ST; Bawa SS; Jain D; Mukund A; Sarin S
    World J Radiol; 2013 Jun; 5(6):229-40. PubMed ID: 23807901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.